Staff surface Definitions and reviews

Definition library

Every executable definition, side-panel definition and catalogue entry, in three groups by the licence of its source, with its threshold in our own words and the source it is cited to. All are drafts pending review; a definition shows as reviewed only when both a clinical and a coding approval are recorded. Default set library_default_set@1.1.

Local criteria: site choices among published definitions and named local variants of the side-panel definitions, each with a change record, two approvals and an outcome preview.

Coder worklist

75 entries
0 reviewed
0 changes requested
75 pending review

Setting: show extended capabilities on clinician screens

Current on clinician screens: Off (default) When on, findings from extended definitions appear on the side panel and the per-note screen under their own heading, after the core findings. Off or on, every check runs and replays the same, and the coder view shows both groups. The guided demo's four cases are unaffected.

CDI or coding staff can change this setting: switch the demo user.

Licence status

Thresholds are stated in our own words. Verbatim text is kept only from U.S. government works and openly licensed (CC BY) sources, with the attribution the licence asks for; copyrighted guidelines are cited by title, body and year, with a locator. No endorsement by the cited bodies is implied. This is not legal advice: counsel should review before commercial release.

Cancer-treatment adverse-event grading scale (NCI CTCAE): off by default

CTCAE grades describe adverse events in people receiving cancer treatment, usually in trials; they are not diagnostic criteria, and several grades depend on the laboratory reference range or on clinical descriptors that are not encoded. Using them outside that setting is a local decision for the clinical reviewer.

Current: Off (default) When on, grading entries are shown only as "another published definition gives …" or as values needing clinical judgement; they never raise a "not stated" item.

CDI or coding staff can change this setting. A clinician account records clinical reviews; a coding or documentation account records coding reviews: switch the demo user.

2 of 75 entries shown.

Thyroid stimulating hormone increased (CTCAE v5.0) and thyroid dysfunction by TSH ctcae5_tsh_increased catalogue Retired Draft · pending review draft — pending clinical and coding review

Status: draft — pending clinical and coding review (draft — requires clinical and coding review)
Condition: Thyroid dysfunction
Tier: 2
Licence: Retired
Source checked: opened on 2026-11-14: Opened by the build that encoded this entry; the threshold matches the opened text.
Use here: catalogue (not executable)
Edition: 2017
Why not executable: TSH thresholds depend on the laboratory reference range, age and pregnancy, and hypothyroidism/hyperthyroidism also need free T4/T3 and clinical context. CTCAE v5.0 grades only 'TSH increased and no intervention initiated' (grade 1) and sends anything treated to 'Hypothyroidism'. Without the laboratory range and free hormone levels the answer would be 'not assessable', so no executable entry is offered. No guideline with fixed TSH cut-offs was opened.

Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0

ctcae5_tsh_increased

In our words: Adverse-event grade by management, not by value; nothing executable.

TSH increased and no intervention initiated

National Cancer Institute, Cancer Therapy Evaluation Program (U.S. Department of Health and Human Services) (2017) · PDF page 89 (5x7 quick reference), term 'Thyroid stimulating hormone increased' (published November 27, 2017) · source

retired: Retired with the CTCAE entries: an adverse-event grading scale for cancer treatment, not a diagnostic definition. No endorsement by the cited bodies is implied.

Review

Reviewed only when both a clinical review and a coding review are recorded as approved.

Clinical review: none recorded yet.

Coding review: none recorded yet.

Hypophosphataemia grade (CTCAE v6.0) ctcae6_hypophosphataemia catalogue Retired Draft · pending review draft — pending clinical and coding review

Status: draft — pending clinical and coding review (draft — requires clinical and coding review)
Condition: Hypophosphataemia
Tier: 2
Licence: Retired
Source checked: opened on 2026-11-14: Opened by the build that encoded this entry; the threshold matches the opened text.
Use here: catalogue (not executable)
Edition: 2025
Why not executable: CTCAE v6.0 grades hypophosphataemia by management, not by value: grade 1 'Laboratory finding only and intervention not indicated', grade 2 'Oral replacement therapy indicated', grade 3 hospitalisation, grade 4 life-threatening. No numeric threshold to execute. No other numeric definition was opened.

Common Terminology Criteria for Adverse Events (CTCAE) v6.0 (MedDRA 28.0)

ctcae6_hypophosphataemia